Does ramelteon (rozerem) work on the first night it's taken for adults with insomnia characterized by difficulties with sleep initiation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Ramelteon Work the First Night?

Yes, ramelteon demonstrates efficacy on the first night of use, with FDA-approved clinical trials showing significant reductions in sleep latency on nights 1 and 2 of treatment compared to placebo. 1

First-Night Efficacy Evidence

The FDA label provides the strongest evidence for first-night effectiveness:

  • In a first-night-effect model of transient insomnia, ramelteon demonstrated a statistically significant decrease in mean latency to persistent sleep compared to placebo when healthy adults took it before spending one night in a sleep laboratory. 1

  • In chronic insomnia trials, polysomnography performed on the first two nights of Week 1 showed ramelteon reduced average latency to persistent sleep at each time point compared to placebo. 1

  • Pooled analysis of four randomized controlled trials found ramelteon 8 mg reduced sleep latency by approximately 13 minutes more than placebo on nights 1 and 2 of treatment (mean LPS 30.2 minutes for ramelteon vs 43.3 minutes for placebo, p < 0.001). 2

Magnitude of First-Night Effect

The American Academy of Sleep Medicine quantifies the first-night benefit:

  • Meta-analysis shows ramelteon 8 mg reduces objective sleep latency by approximately 9-13 minutes compared to placebo, with this effect evident from the first night. 3, 4

  • Approximately 63-66% of patients achieved ≥50% reduction in sleep latency at week 1 with the 8 mg dose. 4

  • The standard 8 mg dose is what clinical trials supporting first-night efficacy were based on; the 16 mg dose conferred no additional benefit and was associated with higher incidences of fatigue, headache, and next-day somnolence. 3, 1

Clinical Context and Limitations

While ramelteon works on the first night, the American Academy of Sleep Medicine provides only a WEAK recommendation due to marginal efficacy, though benefits appear to outweigh minimal harms. 3, 4

  • Ramelteon primarily reduces sleep latency but has minimal to no clinically significant effect on total sleep time (mean increase of only 6.58 minutes), wake after sleep onset, sleep efficiency, or sleep quality. 4

  • The medication has a very short half-life and is particularly effective at reducing sleep latency but has little effect on waking after sleep onset. 3

Safety on First Night

  • No evidence of significant next-day drowsiness or residual effects was found in studies assessing first-night use, with ramelteon showing no significant differences from placebo on next-day cognitive testing. 5, 1

  • No abuse potential or withdrawal effects have been observed, making it suitable for patients with substance use history. 3, 4

Practical Prescribing for First-Night Use

Prescribe ramelteon 8 mg to be taken approximately 30 minutes before bedtime for patients with sleep onset insomnia who need immediate relief. 3, 6

  • Do not prescribe ramelteon for sleep maintenance insomnia (frequent awakenings or early morning awakening), as it has no clinically meaningful effect on wake after sleep onset. 4

  • If ineffective after 1-2 weeks, consider alternative agents rather than increasing the dose, as 8 mg is the maximum approved dose. 4

  • Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the initial treatment before or alongside ramelteon. 3, 4

References

Guideline

Insomnia Treatment with Ramelteon and Quetiapine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ramelteon Efficacy and Safety for Adult Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ramelteon and Next-Day Drowsiness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A review of ramelteon in the treatment of sleep disorders.

Neuropsychiatric disease and treatment, 2008

Related Questions

What is the maximum nightly dose of ramelteon (Rozerem) that can be taken?
What is the best medication for insomnia, specifically comparing ramelteon (Rozerem) to other options?
Is Ramelteon (melatonin receptor agonist) effective for treating insomnia characterized by difficulties with sleep initiation?
What is the best option between mirtazepine, quetiapine, and ramelteon for treating insomnia in a patient with a complex medical history?
What is the recommended dosage and treatment guidelines for Ramaelteon (ramelteon) for insomnia?
What is the recommended initial imaging test for a patient suspected of having complicated diverticulitis, especially with symptoms such as severe abdominal pain, fever, or signs of peritonitis?
Is a computed tomography (CT) scan of the head needed for a pediatric patient who has fallen and is experiencing vomiting?
What are the recommended ventilation parameters and prophylactic measures for a patient on mechanical ventilation (MV) with risk of venous thromboembolism (VTE)?
What are the criteria for thrombectomy in a patient with pulmonary embolism (PE), considering factors such as shock, hypotension, right ventricular dysfunction, age, comorbidities, and prior history of bleeding or thrombotic events?
When is it indicated to wean a patient from mechanical ventilation (MV)?
What is the preferred treatment between fluoxetine (Prozac) and sertraline (Zoloft) for a female patient of childbearing age with a history of postpartum depression and possible obsessive-compulsive disorder (OCD) symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.